Tocilizumab may improve survival in sickest COVID-19 patients, scientists say
In the observational study, the researchers noted that 210 patients received tocilizumab, and the other 420 did not.Tocilizumab, a drug normally used in rheumatoid arthritis and cancer treatments, may improve…